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Background: As the demand for monoclonal antibodies (mAb) increases, more efficient expression methods are
required for their manufacturing process. Transcriptional gene silencing is a common phenomenon in recombinant
cell lines which leads to expression reduction and instability. There are reports on improved antibody expression in
ubiquitous chromatin opening element (UCOE) containing both heavy and light chain gene constructs. Here we
investigate the impact of having these elements as part of the light chain, heavy chain or both genes during cell
line development. In this regard, non-UCOE and UCOE vectors were constructed and stable Chinese hamster ovary
(CHO) cell pools were generated by different vector combinations.
Results: Expression analysis revealed that all UCOE cell pools had higher antibody yields compared to non-UCOE
cells, Moreover the most optimal expression was obtained by cells containing just the UCOE on heavy chain. In
terms of stability, it was shown that the high level of expression was kept consistence for more than four months
in these cells whereas the expression titers were reduced in the other UCOE pools.
Conclusions: In conclusion, UCOE significantly enhanced the level and stability of antibody expression and the use
of this element with heavy chain provided more stable cell lines with higher production level.
Keywords: Cell line development, Chinese hamster ovary (CHO), Monoclonal antibody (mAb), Ubiquitous
chromatin opening elements (UCOE)Background
Therapeutic recombinant monoclonal antibodies (mAbs)
have become a major sector in the biopharmaceutical in-
dustry [1]. Currently, about fifty mAbs have been ap-
proved for the treatment of a variety of diseases which
include cancer, autoimmunity, infectious diseases, and
cardiovascular disorders [2, 3]. Improved methods and
technologies need to be utilized, to meet the growing de-
mand for mAbs [4]. Due to high structural complexity
and sophisticated post transcriptional modification re-
quirements, mammalian expression systems particularly* Correspondence: f_davami@pasteur.ac.ir
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turing [5]. However, generation of stable and high-
yielding mammalian cell lines remain one of the most
significant challenging issues facing researchers in the
field of cell line development [5, 6].
Recent studies have indicated that this inefficiency is
mainly caused by transcriptional silencing of heavy chain
(HC) and light chain (LC) genes with no loss of recom-
binant gene copies [7–9]. DNA methylation especially at
promoter CpG islands plays an important role in trans-
gene transcription silencing [9–11]. It has been reported
that the use of cis-acting epigenetic regulatory elements
such as locus control regions (LCRs), matrix attachment
regions (MARs) and ubiquitous chromatin opening ele-
ments (UCOEs) can protect transgenes from suchle is distributed under the terms of the Creative Commons Attribution 4.0
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silencing elements, the incorporation of UCOEs into the
expression vectors enhances the stability and expression
level of transgenes in mammalian cells. UCOEs are
methylation-free CpG Islands which are located within
the promoter of ubiquitously expressed housekeeping
genes. UCOE from the human HNRPA2B1-CBX3 locus
(A2UCOE) has been used in combination with plasmid
and lentiviral vectors for recombinant protein expression
and gene therapy strategies, respectively [16–22].
Heterotetramer mAb molecules consist of two identical
HC and two identical LC polypeptides. UCOE has already
been exploited to improve mAb expression and stability,
however it has been incorporated into both the heavy chain
and light chain genes and the separate effect of this element
on antibody chains remains to be evaluated [16, 21, 23]. To
the best knowledge of the authors, this is the first study
where the distinct effect of UCOE on H and L chains is
assessed. To this end, non-UCOE and UCOE heavy and
light chain vectors of a model antibody were constructed.
Then stable CHO cell pools were developed by different
vector combinations: non-UCOE vectors (CHO-HL),
UCOE vectors (CHO-UHUL), UCOE heavy chain and
non-UCOE light chain vectors (CHO-UHL) and non-
UCOE heavy chain and UCOE light chain vectors (CHO-
HUL). The expression vector sets used for the generation
of CHO cell pools are summarized in Table 1. Finally, mAb
production studies which include mRNA and protein
expression levels, long-term stability and clonal cell line ex-
pression were compared between constructed pools. This
study provides considerable applications in mammalian cell
line development for more improved antibody expression.
Methods
Antibody expression vector construction
A humanized IgG1 monoclonal antibody MAb0014 was
chosen as the model antibody in this work. HC (gamma
1) and LC (kappa) cDNAs were commercially synthe-
sized (Genscript) and cloned into separate expression
plasmid vectors under the control of the same human
cytomegalovirus (CMV) immediate-early enhancer and
promoter. HC cDNA sequence was cloned into the
pTracer-CMV2 vector (Invirtogen) which contained the
zeocin resistance gene for selection of transfected cells.
LC cDNA sequence was cloned into the pIRES2-DsRed2
vector (Clontech) with neomycin resistance gene. HeavyTable 1 Summary of the expression vectors used for the generation
Cell pool name Expression vector used for heavy
CHO-HL pTracer-CMV2- HC (pH)
CHO-UHUL pTracer-CMV2-UCOE-HC (pUH)
CHO-UHL pTracer-CMV2-UCOE-HC (pUH)
CHO-HUL pTracer-CMV2-HC (pH)and light chain expression vectors were termed pH and
pL, respectively. To construct UCOE containing vectors,
synthesized 2.8 kb A2UCOE sequence (Genscript) was
inserted into the upstream of CMV promoter of pH and
pL vectors. These UCOE containing vectors were named
pUH and pUL, respectively. The schematic maps of plas-
mid vectors used in this study are showed in Fig. 1. All
vectors were constructed based on standard cloning
methods [24]. The cloned sequences were confirmed by
DNA sequencing.
Cell culture
Suspension CHO DG44 host cell line (Life Technologies)
(Catalog no: A10971-01) was used for antibody produc-
tion. CHO cells were cultured in protein-free CD CHO
medium (Life Technologies) supplemented with 8 mM L-
glutamine (Life Technologies) and 1% penicillin/strepto-
mycin (100 μg/mL) (Life Technologies) in disposable
vented cap flasks and at 37 °C in humidified atmosphere
of 5% CO2. Cells were routinely subcultured every three
days at a density of 2–3 × 105 cells/mL. Viable cell density
was determined by using trypan blue (Sigma-Aldrich) ex-
clusion method in duplicates [25].
Transfection, stable cell pool generation and clonal
isolation
Transfection was performed in duplicates in 6-well plates,
2 × 106 cells were seeded in 2 mL CD CHO medium and
transfected with 3 μg linearized plasmid DNA, using X-
tremeGENE HP DNA transfection reagent (Roche) accord-
ing to the manufacturer’s instructions.
To generate stable cell pools, CHO cells were trans-
fected with LC vectors (pL or pUL) and selected with
Geneticin (G418) (400 μg/mL) (Sigma-Aldrich) 72 h
post-transfection. Cells were kept for about 4 weeks, and
during this time period fresh medium with selection
agent was added every three days until cell viability
reach over 95%.
Thereafter, cells were transfected with HC vectors (pH
or pUH) and selected with zeocin (500 μg/mL) (Life Tech-
nologies) 72 h post-transfection for 4 weeks. Finally, trans-
fectants were cultured under dual G418 (400 μg/mL) and
zeocin (500 μg/mL) selection pressure for up to 2 weeks.
Four different cell pools were generated by transfection of
pH and pL vectors (CHO-HL), pUH and pUL vectors
(CHO-UHUL), pUH and pL vectors (CHO-UHL), and pHof CHO cell pools





Fig. 1 The schematic structure of plasmid vectors constructed and used in the studies. a Heavy chain coding plasmid vectors; pTracer-CMV2-HC
(pH) and pTracer-CMV2-UCOE-HC (pUH). b Light chain coding plasmid vectors; pIRES2-DsRed2-LC (pL) and pIRES2-DsRed2-UCOE-LC (pUL)
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and antibiotic selection steps, cell pools were passaged
several times and transferred in duplicate into 6-well
plates at a density of 5 × 105 cells/mL for 7 days. Cul-
ture medium of stable cell pools were harvested at the
end of batch culture and centrifuged at 4 °C 1100 rpm
for 10 min. The supernatants were collected into a
fresh 1,5 mL tubes and stored at −20 °C for further ex-
pression analysis by western blot and enzyme-linked
immunosorbent assay (ELISA). Single-cell clones were
isolated from cell pools using standard limiting dilu-
tion. In brief, cells were seeded in 96-well plates at a
density of 1 cell per well in 200 μl of CHO medium
(Life Technologies) with supplements in the absence of
G418 or zeocin selection pressure. After 21 days, recov-
ered clones were transferred into 24-well plates. For
each cell pool, fifty clones were randomly scaled up into
12-well plates and 7 days later their supernatants were
collected for antibody expression screening by ELISA
and then three clones that had the highest mAb levels
were selected for specific productivity analysis.Cell-specific productivity evaluation
To evaluate cell-specific productivity of selected clones,
3 × 105 cells/mL were seeded in duplicate in CD CHO
medium (Life Technologies) with supplements in 6-well
plates for up to 7 days and sampled daily to measure vi-
able cell density and antibody titer. The viable cell density
was evaluated by trypan blue (Sigma-Aldrich) exclusion
method and antibody concentration was measured using
ELISA. Cell-specific productivity (qmAb; pg/cell/day) was
determined by plotting antibody titer (μg/mL) against the
integral of viable cells (IVC) for 2–4 days.Production stability study
In order to study the long-term stability of antibody pro-
duction, duplicate samples of CHO cells were maintained
in suspension culture in the absence of (G418) and zeocin
selective pressure for over 4 months. Routinely, every
2 weeks, cells were sampled to measure antibody titer by
ELISA. Cells were seeded at 5 × 105 cells/mL density in 6-well plates and supernatants were collected 7 days later for
antibody titer measurement.
Antibody quantification by ELISA
The monoclonal antibody concentration was measured by
capture ELISA. Multi-well strips (Thermo Scientific Nunc)
were coated with 100 μl rabbit anti-human IgG Fc gamma
capture antibody (Thermo Scientific Pierce) at 1:16000 di-
lution in coating buffer (50 mM NaHCO3, pH 9) and incu-
bated at 4 °C overnight. Wells were blocked with 150 μl
PBS containing 1% (w/v) bovine serum albumin for 1 h at
37 °C. Sample culture supernatants (diluted in PBS if neces-
sary) were loaded into wells in triplicate and incubated for
1 h at 37 °C. Horseradish peroxidase (HRP) conjugated goat
anti-human IgG detector antibody (Sigma-Aldrich) was
added at 1:32000 dilution and incubated for 1 h at 37 °C.
100 μl tetramethyl-benzidine (TMB) peroxidase substrate
(Sigma-Aldrich) was added and proceeded at RT in the
dark for up to 30 min. Finally, 100 μl 1 N H2SO4 (Merk)
was added to stop the reaction and absorbance was mea-
sured at 450 nm using a PowerWave XSTM (BioTek) mi-
croplate reader. In all the experiments, a standard curve
was generated using serial dilutions of standard human IgG
(Genscript) and untransfected cell culture medium was
used as a negative control.
Western blot analysis
Supernatant of stably transfected CHO pools were sub-
jected to standard reducing 12% polyacrylamide gel
SDS-PAGE. The separated samples were transferred
onto nitrocellulose membrane (GE Healthcare) using the
Trans-Blot SD semi-dry transfer cell (Bio-Rad). The
membrane was washed with PBS supplemented with
0.025% [v/v] Tween 20 and blocked with 5% skimmed
milk (Merk) in PBS at 4 °C overnight. Then stained with
HRP conjugated goat anti-human IgG at 1:5000 in
PBS (Sigma-Aldrich) at RT for 1 h and developed
using 3,3 -diaminobenzidin (DAB) peroxidase sub-
strate (Sigma-Aldrich). Human IgG (Genscript) with
known concentration and culture medium from
untransfected cells were used as positive and negative
control in every experiment, respectively.
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Total RNA was extracted from 106 cells using the TRIr-
eagent (Sigma-Aldrich) following the manufacturer’s in-
struction. The isolated RNA was treated with RNase-free
DNaseI (Thermo Scientific) to eliminate DNA contam-
ination. The quantity and quality of RNA were deter-
mined using the Nanodrop 1000 spectrophotometer
(Thermo Scientific). cDNA synthesis was performed
using Transcriptor First Strand cDNA Synthesis Kit
(Roche) according to the manufacturer’s instruction.
Genomic DNA extraction
Genomic DNA was extracted from 106 cells using DNA
isolation kit (Roche) according to the manufacturer’s man-
ual. DNA concentration and purity was measured using
Nanodrop 1000 spectrophotometer (Thermo Scientific).
mRNA level and gene copy number analysis
Quantitative real-time PCR (qRT-PCR) was used to de-
termine the HC and LC mRNA levels, as well as the
gene copy numbers. Specific HC, LC, GAPDH and β-
actin primers were designed using the Primer Express
software 3 (Applied Biosystems). The following primer
sets were used: HC, forward 5′- CGACGGCTCCACFig. 2 Antibody concentrations of different stable cell pools. a Antibody expres
represent standard deviation of triplicate ELISA measurements. Data was statistic
generated cell pools (p < 0.05). b Western blot analysis of reduced supern
The appearance of bands with the expected size of 50 KD for heavy chain an
(untransfected cell culture medium) (lane 1), Positive control (human IgG) (lan
CHO-HL (lane 4), CHO-HUL (lane 5), CHO-UHUL (lane 6) and CHO-UHL (lane 7AAACTATAATCC-3′; reverse 5′-TGCCAGTGACCGA
AATAGTGAGAC-3′, LC, forward 5′-CAGAGTGTG
GACTACGATGGAGAC-3′; reverse 5′-CGGAGCCTG
AGAACCTGGATG-3′, GAPDH, forward 5′-CACTCTT
CCACCTTTGATGCTG-3′; reverse 5′-GTCCACCACT
CTGTTGCTGTAGC-3′, β-actin, forward 5′-AAGTGTG
ACGTCGACATCCGCAAAGAC-3′; reverse 5′-GGTTG
ACCTGGAAGGGCCCATCATG-3′. GAPDH and β-
actin housekeeping genes were used as the internal con-
trol for normalizing RNA and DNA variation, respectively.
Amplification was performed using a SYBR Green master
mix (Applied Biosystems) in an ABI 7500 system (Applied
Biosystems). The thermal profile for the real-time PCR
was 95 °C for 5 min followed by 40 cycles at 95 °C for 15 s
and 60 °C for 1 min. The specificity of amplification was
confirmed by melt curve analysis following a thermal cycle
as follows: 95 °C for 15 min, 60 °C for 30 min and 95 °C
for 15 min. HC and LC cDNA-containing plasmid vectors
were used as templates to generate standard curves.
GAPDH and β-actin standard curves were generated
using a chosen cDNA and DNA samples as templates, re-
spectively. All standard dilutions, negative control and
samples were assayed in triplicate. Relative quantification
analysis was calculated using the Pfaffl method [26].sion levels from generated pools were measured by ELISA. The error bars
ally analyzed using ANOVA to detect significant differences between the
atants from four pools using HRP conjugated goat anti-human IgG.
d 25 KD for light chain verified the presence of antibody. Negative control
e 2), protein molecular weight marker (lane 3), sample supernatants of
)
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Expression analysis data was statistically analyzed using
the one-way ANOVA test in GraphPad Prism 6 software
environment to detect significant differences in mAb
production between the generated cell pools. For all stat-
istical analyses a value of p <0.05 was the level of statis-
tical significance.
Results
The effect of UCOE on antibody expression level in stable
CHO cell pools
In order to evaluate the distinct impact of UCOE on HC
and LC and find the optimal expression condition for anti-
body production in CHO cells, four stable pools were gen-
erated. The non-UCOE CHO-HL pool expressed both
antibody chains without UCOE regulation and was used
as a control. The CHO-UHUL pool expressed HC and LC
under the UCOE control and was used as a conventional
UCOE system. CHO-UHL and CHO-HUL expressed just
HC and LC under the UCOE regulation, respectively.
Antibody expression level was compared between recov-
ered pools, following the transfection of linearized plasmid
vectors and selection with G418 (400 μg/mL) and zeocin
(500 μg/mL). Duplicate samples for each cell pool were
collected and measured by ELISA. The level of antibody
expression is shown in Fig. 2a. In comparison with the
non-UCOE control cell pool, all UCOE pools gave consid-
erably higher antibody yields and different combinationsFig. 3 Antibody mRNA levels and gene copy numbers of the stable cell pools.
with antibody expression levels. b Relative HC, LC gene copy numbers were me
independent qRT-PCR assays. Data was statistically analyzed using ANOVA to deof UCOE containing HC and LC constructs showed differ-
ent expression levels. Analysis between UCOE pools
showed that the expression level driven by CHO-UHL was
greater than other UCOE cell pools. Expression level of
CHO-UHL was 6.5 mg/L and about 8 times more than
the CHO-HUL cells with 0.8 mg/L, and 5 folds higher
than the conventional UCOE system (CHO-UHUL) with
1.2 mg/L. Moreover, Western blot analysis clearly verified
the relative difference of antibody productivity between
samples (Fig. 2b). In line with previous studies, these re-
sults indicate that the inclusion of UCOE on antibody
chains provides a substantial improvement in CHO cell
productivity [16, 21]. Based on the cell pools studied in the
present work, it seems that utilization of this element on
HC facilitates antibody expression.
Effect of UCOE on antibody mRNA level and gene copy
number
The HC and LC mRNA levels were measured by qRT-
PCR (Fig. 3a). All UCOE pools showed higher HC and
LC mRNA contents in association with their antibody ti-
ters, as compared to the non-UCOE pool. This suggests
that UCOE, probably, increases productivity through en-
hancement of mRNA expression. The HC and LC
mRNA levels of pools were also compared with their
antibody titers (Fig. 3a). Subsequently, a positive correl-
ation between HC mRNA level and the measured anti-
body concentration was found.a Relative HC, LC mRNA levels were determined by qRT-PCR and compared
asured by qRT-PCR. The error bars represent standard deviation of three
tect significant differences between the generated cell pools (p< 0.05)
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assess HC and LC gene copy numbers (Fig. 3b). As
shown in Fig. 3b, the UCOE pools had almost about 2
and 3 copies of HC and LC, respectively, and control
non-UCOE pool had 3 copies of HC and 10 copies of
LC which indicated no apparent correlation between
antibody production and copy number of recombinant
genes.Evaluation of antibody expression of the stable clones
Stable clones were obtained by limiting dilution in the ab-
sence of antibiotic selective pressure. Forty random clones
were picked and transferred into 24-well plates for each
stably transfected pool. Antibody expression was measured
by ELISA. Fig. 4a clearly shows that among clones derived
from non-UCOE CHO-HL pool, only about 8% were able
to express detectable level of antibody, while all UCOE
containing cell pools showed significantly more positive
antibody producing clones (Fig. 4b, c, d). CHO-UHUL and
CHO-HUL pools had 80 and 60% positive clones, respect-
ively. Interestingly, all clones from CHO-UHL pool pro-
duced antibody.Fig. 4 Antibody expression levels of clonal cell lines from CHO-HL a CHO-H
highest to lowest. Data was statistically analyzed using ANOVA to detect siThe average expression level detected in non-UCOE
CHO-HL positive clones was about 0.08 mg/L, whereas
it was about 1.2 mg/L in CHO-UHUL and CHO-HUL
and 6.2 mg/L in CHO-UHL clones. These results dem-
onstrate that UCOE could increase number of antibody
expressing clones.
The best three expressing clones of each cell pool were
selected to assess the cell-specific productivity. 3 × 105
cells/mL were maintained in 24-well plates, and viable cell
density and antibody titer were measured daily to calcu-
late the specific productivity. The specific productivity of
the clones obtained in the presence of UCOE was greater
than that of the clones obtained in the absence of this
element (Fig. 5). Comparison between the UCOE clones
revealed that the average productivity of selected clones of
CHO-UHUL and CHO-HUL was similar and isolated
clones from CHO-UHL had the highest productivity.
Effect of UCOE on antibody expression stability
In order to compare the long-term stability of antibody
expression between generated stable pools, cells were cul-
tivated in the absence of selective pressure for 4 months.
Antibody titer was calculated every 2 weeks by ELISA.UL (b), CHO-UHUL (c), CHO-UHL (d) pools are shown and ranked from
gnificant differences between the generated cell pools (p < 0.05)
Fig. 5 Comparison of specific antibody productivity (qmAb) [pg/cell/
day] of three isolated clones from each cell pools. The error bars
represent standard deviation of triplicate measurements. Data was
statistically analyzed using ANOVA to detect significant differences
between the generated cell pools (p < 0.05)
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pools remained higher than the non-UCOE cell pool over
a long-term culture (Fig. 6). As shown in Fig. 6, expression
level of the non-UCOE CHO-HL pool decreased much
more rapidly by up to 90%, whereas it was slightly reduced
by 50% for the CHO-UHUL and CHO-HUL pools. CHO-
UHL maintained its expression level during this period.
Consequently, in accordance with previous reports, UCOE
gives higher production stability during long-term cultiva-
tion and based on the findings of the present work, it
could be concluded that the addition of UCOE to HC not
only maximizes antibody expression level but also pro-
vides more stable productivity [17].
Discussion
To our best knowledge, previous studies used UCOE elem-
ent in combination with both heavy and light chains for en-
hanced antibody production [16, 21, 23]. In this study, theFig. 6 Long-term antibody expression levels of the stable cell pools. The
error bars represent standard deviation of three experiment replicates
Data was statistically analyzed using ANOVA to detect significant
differences between the generated cell pools (p< 0.05)individual effect of UCOE on HC and LC was investigated
to find the optimal condition for antibody expression and
stability.
At first, heavy and light chain encoding plasmid vectors
were constructed. Then the UCOE containing versions of
each vector were generated. The constructed vectors
transfected into CHO-DG44 cells and four stable pools
were developed: non-UCOE cell pool (CHO-HL), and
three UCOE cell pools which one of them expressed both
antibody chains under UCOE control (CHO-UHUL) and
the two other cell pools expressed just HC or LC under
UCOE regulation (CHO-UHL and CHO-HUL).
In agreement with other published works, it was found
that UCOE containing pools had higher antibody titers
when compared with the control cell pool lacking this
element [16, 17, 21]. Additionally, expression analysis by
ELISA and western blot showed the CHO-UHL pool,
only expressing HC under the control of UCOE resulted
in significantly higher antibody level than other UCOE
pools. It was about 8- and 5-folds higher than the CHO-
HUL and CHO-UHUL pools, respectively. The expres-
sion level of CHO-UHUL was about 1.5 times greater
than that of CHO-HUL.
To find the possible reason for differences in antibody
production, HC and LC mRNA expression and gene copy
numbers were analyzed. It was observed that despite the
lower copy number of HC and LC genes, all UCOE cell
pools had greater mRNA levels. Hence, in agreement with
previous data, it was shown that UCOE could exert its ef-
fect by enhancing transcription without any distinguish-
able increase in copy numbers of integrated transgenes
[17, 27]. Comparison of HC and LC mRNA levels with
antibody concentrations showed a direct correlation be-
tween antibody titers and heavy chain mRNA levels.
In addition, antibody expression analysis was performed
on clonal cell lines. Among analyzed clones, UCOE con-
taining pools showed more positive clones with higher
antibody yields than the non-UCOE pool. This is consist-
ent with the fact that more antibody secreting cell lines
were obtained in the presence of UCOE [21, 28] probably
due to its insulating effect on transgene expression. As ex-
pected, the number of positive clones and antibody levels
were significantly greater in CHO-UHL and all colonies
from this pool expressed mAb with an average of 6.2 mg/L
which could indicate higher expression level for this pool.
On the other hand, CHO-UHUL had more number of
positive clones than CHO-HUL and the average antibody
levels of both were approximately similar. These results
suggested that expression up-regulation of antibody chains
through UCOE could increase the number of antibody se-
creting clones and consequently improve productivity.
What’s more, our findings indicated that up-regulation of
HC expression may result in more positive clones and
antibody production rates.
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ant protein production in CHO cells by improvement in
gene expression. In terms of monoclonal antibody the
comparative study between generated UCOE containing
cell pools indicated that the optimal antibody yields were
obtained from CHO-UHL cells. Although, enhancement
of LC expression appears to increase antibody production
(CHO-HUL), improvement of HC expression has signifi-
cantly more impact on secreted antibody levels (CHO-
UHUL and CHO-UHL), and also the interesting point is
that the enhancement of HC expression, has a better ef-
fect in comparison with enhancement of both HC and
LC. In comparison with conventional CHO-UHUL system
fortified HC expression by UCOE in CHO-UHL pool lead
to more positive antibody secreting clones with higher
specific productivity which finally resulted in higher anti-
body yield in this cell pool. In some previous publications
it was indicated that expression of LC is more efficient
than HC, and antibody production is limited by the ex-
pression of HC [29, 30]. Also, in some mRNA expression
analysis it was reported that antibody productivity has a
better correlation with HC rather than LC expression
levels [30–32]. Therefore, because HC is a more limited
component than LC, its expression enhancement may
allow for better formation of the antibody. So it was de-
duced that in CHO-UHL cells HC is no longer limiting
which caused a higher antibody production rate. In other
words, considering the higher LC mRNA levels in CHO-
UHUL compared to CHO-UHL, it seems that if the cell is
in the situation that can produce both LC and HC mRNA
in an epigenetic protected condition, LC transcription and
expression would be dominant probably due to shorter
length and simpler transcript. This, we assume that may
deplete the energy sources towards LC rather than HC
and finally the equal amount of HC and LC which is
needed for proper final folding would not be achieved.
One of the major challenges in the industrial manufac-
turing of antibodies is transgene expression instability
over the long-term culture. Epigenetic changes especially
promoter methylation may result in transcriptional gene
silencing during cultivation. UCOE can prevent expres-
sion instability through reduction in DNA methylation
and heterochromatin formation at the site of transgene
integration [17, 19]. Consequently, we monitored the
antibody expression level stability of UCOE and the
non-UCOE pools over 4 months, in the absence of se-
lective pressure. In general, antibody production
remained more constant in the UCOE pool. Among the
three UCOE cell pools, no considerable change in ex-
pression levels of CHO-UHL was observed. However,
CHO-UHUL and CHO-HUL pools showed expression
reduction, but still maintained their antibody production
levels 40% higher than the non-UCOE pool. So, in line
with previous studies, it was deduced that UCOE couldenhance expression stability over long cultivations and
CHO-UHL is the best system for stable antibody
production.
Conclusions
In conclusion, the results of the present work demon-
strated that incorporation of UCOE in antibody expres-
sion plasmid vectors could result in generation of higher
and more stable expression levels relative to conven-
tional (non- UCOE) control vectors. Among the three
stable UCOE containing pools studied in this work,
CHO-UHL was the most suitable system for improved
stable antibody production. Hence, it is concluded that
HC expression up-regulation provides more optimized
expression conditions relative to enhancement of both
HC and LC expression. The novel system illustrated
here could propose an important alternative to industrial
cell line development approaches.
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